Rome, Nov 11. (Adnkronos Health) – In Italy, approximately 3.8 million people live with a diagnosis of diabetes, representing 6.4% of the population, while over 1 million could be living with the disease without having received a diagnosis. These figures, in view of World Diabetes Day celebrated on November 14, draw attention to the need to strengthen prevention, early diagnosis, and access to personalized care. Over 90% of cases concern type 2 diabetes. On the therapeutic front, the CHMP (Committee for Medicinal Products for Human Use in the European Union) of the EMA – European Medicines Agency recently expressed a favorable opinion on the first combination of weekly basal insulin icodec and weekly semaglutide. The formulation combines two complementary mechanisms of action, with the aim of promoting glycemic control and reducing therapy complexity. After pioneering weekly insulin, Italy could be the first European country to make this innovation available.
“The management of type 2 diabetes cannot be evaluated solely through the achievement of glycemic targets,” states Francesco Giorgino, Professor of Endocrinology at the University of Bari Aldo Moro. The weekly combination can help reduce the number of administrations and the complexity of regimens, supporting adherence and quality of life. The associations’ reception is favorable. “Reducing administrations means lightening the physical and psychological burden of the disease,” emphasizes Manuela Bertaggia, president of Fand – Italian Diabetics Association, appealing to Aifa – Italian Medicines Agency for rapid access. Sid – Italian Society of Diabetology and Amd – Association of Diabetologist Doctors highlight that switching from daily injections to a single weekly administration can concretely simplify care, while maintaining the need for personalization, therapeutic education, and monitoring.
Institutions also call for rapid timelines. Daniela Sbrollini and Roberto Pella, co-presidents of the Parliamentary Intergroup on Obesity, Diabetes, and Non-Communicable Chronic Diseases, hope for timely and equitable access throughout the country. For the Vice President of the Senate Gian Marco Centinaio, Italy must immediately seize “a new opportunity to simplify patients’ lives.” World Day – the note concludes – thus relaunches a decisive challenge: to transform scientific innovation into a concrete, appropriate, and accessible opportunity, so that the quality of care does not depend on the region or social conditions.